First Combined Quarter Reveals a $2B Platform With a Split Personality: AxS Prints Money ($53M EBITDA) While SCDE Barely Breaks Even ($4M) — But the 27% EPS Guide Raise Changes Everything

Results vs. Consensus

Quality of Results

• Revenue (+4.1% beat): The beat was driven by stronger-than-expected legacy AVAV performance ($219.5M, +16% organic) and BlueHalo contributing $235.2M in its first full quarter. The revenue beat combined with the EPS guidance raise suggests that the top-line momentum is flowing through to profitability better than initial integration assumptions modeled.
• EPS (slight miss vs. Q1 consensus, massive raise on full year): The Q1 non-GAAP EPS miss of $0.02 ($0.32 vs. $0.34) is noise — it's the FY guidance raise from $2.80-3.00 to $3.60-3.70 that matters. This implies H2 EPS of ~$3.30-3.38 (FY $3.65 mid - Q1 $0.32 = $3.33 remaining over 3 quarters), or ~$1.11/quarter. This is a dramatic H2 ramp that requires both integration synergies and seasonal LMS strength.
• EBITDA (+52% Y/Y): Adjusted EBITDA of $56.6M at 12.4% margin on $455M revenue establishes the initial combined-company margin baseline. The segment split is revealing: AxS at 18.5% EBITDA margin is healthy; SCDE at 2.2% shows BlueHalo's space and cyber business is essentially a breakeven contribution. The FY guide of $300-320M implies ~$81M/quarter average for the remaining 3 quarters — a significant ramp from Q1's $56.6M that requires SCDE margin improvement.

Segment Performance — The New AVAV

Autonomous Systems: The Profit Engine

AxS at $285.3M and $52.8M EBITDA (18.5% margin) demonstrates that the core autonomous weapons business is not only growing (+51% Y/Y including BlueHalo's autonomous contributions) but highly profitable. Legacy AVAV organic growth of 16% confirms the demand acceleration we've tracked since initiating. Switchblade 600 at +200% revenue growth, Jump-20 at +6x, and LOCUST at +5x show the product portfolio is hitting inflection simultaneously across multiple programs.

Assessment: AxS is a world-class defense segment — 18.5% EBITDA margin with 50%+ growth is rare in defense. This segment alone justifies the premium multiple. The challenge is that AxS's strength is partially masked by SCDE's dilution at the consolidated level. Investors need to model this as a two-business company: a high-growth, high-margin autonomous weapons platform (worth a premium) bolted onto a lower-margin defense services business (worth a market multiple).

Space, Cyber & Directed Energy: The BlueHalo Reality

SCDE at $169.4M and just $3.8M EBITDA (2.2% margin) is the BlueHalo reality check. The segment's revenue is substantial, but its contribution to profitability is negligible in Q1. This likely reflects first-quarter integration costs, BlueHalo's inherently lower-margin government services model (vs. AVAV's higher-margin product sales), and the typical ramp period for newly acquired businesses to reach normalized margins.

Assessment: SCDE's 2.2% EBITDA margin needs to reach 10-12% for the acquisition to be genuinely accretive. At $169M/quarter revenue, every 100bps of margin improvement adds ~$1.7M/quarter ($6.8M annual) in EBITDA. If SCDE can reach 10% margin by FY2027 ($17M/quarter), it becomes a meaningful profit contributor. The FY guidance raise suggests management sees this path — otherwise the $3.60-3.70 EPS wouldn't be achievable.

Key Topics & Management Commentary

Overall Management Tone: Confident and strategically expansive — a CEO who can see the combined platform thesis materializing. Nawabi's language has evolved from product-specific ("Switchblade demand") to platform-level ("air, land, sea, space and cyber"). Integration is described as "progressing ahead of schedule" — a claim backed by the 27% EPS guidance raise. This is the most confident AVAV has sounded since we initiated coverage.

1. The 27% EPS Guidance Raise: What It Means

Raising FY2026 non-GAAP EPS from $2.80-3.00 to $3.60-3.70 after just one quarter of combined operations sends three signals: (1) integration costs are lower than initially modeled, (2) legacy AVAV's organic performance is tracking above plan, and (3) management has visibility into the H2 margin ramp that wasn't evident at the time of the original guide. The implied H2 EPS of ~$1.11/quarter (vs. Q1's $0.32) requires a dramatic step-up — but this is consistent with AVAV's historical seasonality (Q4/Q1 are typically weakest, Q2/Q3 strongest due to DoD fiscal year spending patterns).

"Record revenue and backlog demonstrate strength across both segments with broad portfolio of solutions aligned to customer priorities in air, land, sea, space and cyber." — Wahid Nawabi, CEO

Assessment: The raise is the single most important data point in the report. It transforms the BlueHalo narrative from "dilutive in the near-term, accretive by FY2027" to "accretion tracking ahead of schedule, visible by H2 FY2026." This de-risks the integration thesis by 6-12 months.

2. Gross Margin Collapse: Structural or Fixable?

Consolidated gross margin of 21% (vs. 43% Y/Y) is the most jarring number in the release. The collapse is entirely from BlueHalo's service-heavy revenue mix and purchase accounting amortization — not from legacy AVAV margin deterioration. In fact, legacy AVAV's 16% organic growth at presumably 40%+ gross margins suggests the core business is as healthy as ever.

Assessment: The 21% gross margin is the "new normal" for the combined company, not a distressed signal. Defense services businesses (which is what BlueHalo largely is) typically run 15-25% gross margins vs. 35-45% for product-focused companies like legacy AVAV. Consolidated gross margin should gradually improve toward 25-28% as SCDE scales and integration synergies reduce redundant costs, but 40%+ is no longer achievable at the consolidated level.

3. $1.1B Backlog and Product Traction

Record backlog of $1.1B (up from $727M at fiscal year-end) with 82% revenue visibility to guidance midpoint provides robust demand underpinning. Bookings of $399M in Q1 alone imply an annualized booking rate of ~$1.6B — well above the $1.9-2.0B revenue guide, suggesting continued backlog growth. Individual product traction (Switchblade 600 +200%, Jump-20 +6x, LOCUST +5x) validates that the autonomous weapons supercycle is broadening beyond Switchblade into next-generation platforms.

Assessment: The backlog provides downside protection and forward visibility that is rare in defense at this growth rate. A book-to-bill of ~1.6x (annualized $1.6B bookings vs. $1.95B revenue run rate) means backlog is expanding faster than it's being consumed. This is the definition of a demand environment that exceeds supply capacity.

Guidance & Outlook

Implied H2 ramp: With Q1 non-GAAP EPS at $0.32 and FY guide at $3.65 midpoint, the remaining 3 quarters need ~$3.33 combined (~$1.11/quarter). This is a 3.5x step-up from Q1 — aggressive but achievable if: (1) SCDE margins improve from 2.2% to 8-10% as integration costs decline, (2) AxS maintains 18%+ margins with seasonal strength, and (3) interest expense moderates as debt is repaid.

Note on EBITDA guide: Revenue maintained at $1.95B midpoint with EBITDA maintained at $310M implies ~16% EBITDA margin for the year. Q1 was 12.4%. Reaching 16% for the year requires ~17-18% in H2 — feasible with SCDE margin expansion and AxS seasonal strength.

What They're NOT Saying

1. SCDE margin improvement timeline: At 2.2% EBITDA margin, SCDE needs to improve to 10%+ for the acquisition to be meaningfully accretive. No specific margin targets or timeline were provided.
2. Debt repayment schedule: $725.7M in long-term debt with no explicit deleveraging targets. FCF of ($146.5M) in Q1 means debt isn't being paid down — it's growing.
3. Synergy quantification: The EPS raise implies synergies tracking ahead, but no specific cost or revenue synergy targets have been disclosed. The market is being asked to trust the raise without seeing the underlying math.
4. BlueHalo customer overlap: No disclosure on contract wins that leverage the combined platform (AxS + SCDE cross-sell). This would validate the strategic rationale beyond financial engineering.

Market Reaction

• Pre-earnings: ~$190-195
• Post-earnings: Likely positive on FY EPS guidance raise
• Note: Specific intraday data not confirmed for Sept 9-10 in available sources

The 27% EPS guidance raise is the type of catalyst that typically drives a 5-10% move in defense stocks. The slight Q1 EPS miss ($0.32 vs. $0.34) is a rounding error that the market would look through given the magnitude of the full-year raise. The revenue beat (+4.1%) and record backlog ($1.1B) reinforce the positive narrative. The primary check on euphoria is the GAAP loss ($1.44/share) and the SCDE segment's 2.2% margin — both of which raise legitimate questions about the quality of the combined company's earnings.

Street Perspective

Debate: Does the EPS Raise Validate BlueHalo or Just Mask It?

Bull view: A 27% EPS raise after one quarter proves integration is ahead of plan. Legacy AVAV at +16% organic is the real story — the core business is accelerating and BlueHalo adds scale without destroying the thesis. At $3.65 EPS, the stock at ~$193 trades at 53x — still premium but compressing as earnings ramp in H2.

Bear view: The EPS raise may reflect legacy AVAV outperformance, not BlueHalo synergies. SCDE at 2.2% EBITDA margin is a breakeven government services business — the "platform" thesis requires this segment to achieve 10%+ margins, which hasn't happened yet. And the GAAP loss of ($1.44)/share is a reminder that amortization will consume reported earnings for years.

Our take: Both forces are at work. Legacy AVAV is clearly outperforming (16% organic, Switchblade/Jump-20 traction). BlueHalo's contribution is currently revenue without margin — but the EPS raise implies management sees margin improvement that isn't yet visible in Q1 numbers. The bull case requires patience on SCDE margins; the bear case requires ignoring the guidance raise, which is hard to justify.

Model Update

Valuation: At ~$193 (~$9.5B market cap), AVAV trades at 53x the new FY2026E EPS ($3.65 mid), 31x FY2026E EBITDA ($310M), and ~4.9x revenue. The EPS multiple has compressed from 62x (on $2.90) to 53x (on $3.65) without the stock moving — the guidance raise is providing multiple compression through earnings growth, which is exactly what needs to happen. Target raised to $230-250 based on 55-60x FY2026E EPS or 25-27x EBITDA. Bull case $275+ if SCDE margins reach 10%+ by Q3-Q4.

Thesis Scorecard

Overall: FY26 Q1 confirms the combined platform is real ($455M revenue, $1.1B backlog) and the integration is tracking ahead of plan (27% EPS raise). The primary concern — SCDE's 2.2% margin — is the single metric that separates "BlueHalo is a good acquisition" from "BlueHalo is a great acquisition." Everything else (AxS growth, product traction, demand visibility) supports the Outperform thesis.

Action: Maintain Outperform. Raise target to $230-250 on the new $3.65 EPS midpoint. Monitor: (1) SCDE margin trajectory in Q2-Q3, (2) FCF turning positive for the first time as a combined company, (3) cross-sell evidence (AxS + SCDE contract wins), (4) debt repayment pace.